JAKARTA – PT Brigit Biofarmaka Teknologi Tbk (OBAT) has announced its plans for continuous growth, aiming for a 20% increase this year or even higher.

 

According to an official statement received by IDNFinancials on Monday (13/1), OBAT recorded total sales exceeding IDR 100 billion by the end of 2024, with a net profit reaching IDR 30 billion.

 

Is Heriyanto, President Director of OBAT, also revealed plans to adopt digital marketing strategies to position OBAT as a one-stop maklon (toll manufacturing) service provider.

 

"With this approach, we are confident that OBAT can surpass the 20% target in line with the projections we have shared," continued Machmud Lutfi Huzain, President Commissioner of OBAT. (ZH)

 

Watch the video to know more about OBAT's strategy to achieve this growth target.

You can also read about OBAT's IPO here: